日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer

探讨与胰腺癌个性化肽疫苗临床疗效降低相关的因素

Uchino, Yoshihiro; Muroya, Daisuke; Yoshitomi, Munehiro; Shichijo, Shigeki; Yamada, Akira; Sasada, Tetsuro; Yamada, Teppei; Okuda, Koji; Itoh, Kyogo; Yutani, Shigeru

Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers

针对泌尿系统癌症,通过多肽疫苗接种筛选相关肽段,进行生存分析

Noguchi, Masanori; Koga, Noriko; Moriya, Fukuko; Suekane, Shigetaka; Yutani, Shigeru; Yamada, Akira; Shichijo, Shigeki; Kakuma, Tatuyuki; Itoh, Kyogo

Development of Lobular Panniculitis Long After Completing the Personalized Peptide Vaccine Therapy

个性化肽疫苗治疗结束后很久仍出现小叶性脂膜炎

Uchida, Aira; Kawasaki, Eiji; Tojikubo, Masayuki; Tamai, Hidekazu; Sagara, Yoko; Nakano, Yuko; Uji, Yoshitaka; Masuda, Masanori; Yamaguchi, Takahiro; Yutani, Shigeru

Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11(+) or -A33(+) allele

对携带 HLA -A11(+) 或 -A33(+) 等位基因的癌症患者进行肽疫苗免疫学评估

Sakamoto, Shinjiro; Matsueda, Satoko; Takamori, Shinzo; Toh, Uhi; Noguchi, Masanori; Yutani, Shigeru; Yamada, Akira; Shichijo, Shigeki; Yamada, Teppei; Suekane, Shigetaka; Kawano, Kouichiro; Naitou, Masayasu; Sasada, Tetsuro; Hattori, Noboru; Kohno, Nobuoki; Itoh, Kyogo

Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies

对局部区域治疗无效的肝细胞癌患者进行个性化肽疫苗接种的可行性研究

Yutani, Shigeru; Shirahama, Takahisa; Muroya, Daisuke; Matsueda, Satoko; Yamaguchi, Rin; Morita, Michi; Shichijo, Shigeki; Yamada, Akira; Sasada, Tetsuro; Itoh, Kyogo

Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma

个性化肽疫苗作为转移性上尿路尿路上皮癌的二线治疗

Suekane, Shigetaka; Ueda, Kousuke; Nishihara, Kiyoaki; Sasada, Tetsuro; Yamashita, Takuto; Koga, Noriko; Yutani, Shigeru; Shichijo, Shigeki; Itoh, Kyogo; Igawa, Tsukasa; Noguchi, Masanori

Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site

对组织学预后不良的原发灶不明癌患者进行个性化肽疫苗免疫学评估

Sakamoto, Shinjiro; Yutani, Shigeru; Shichijo, Shigeki; Morita, Michi; Yamada, Akira; Itoh, Kyogo; Noguchi, Masanori

Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer

个性化汉方医学促进了细胞毒性T淋巴细胞反应,并增强了个性化肽疫苗治疗晚期食管癌的临床疗效

Muroya, Daisuke; Yutani, Shigeru; Shichijo, Shigeki; Yamada, Akira; Sakamoto, Shinjiro; Naito, Masayasu; Okuda, Koji; Morita, Michi; Yamaguchi, Rin; Itoh, Kyogo

Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele

对携带 HLA-A26 等位基因的癌症患者进行肽疫苗免疫学评估

Sakamoto, Shinjiro; Matsueda, Satoko; Takamori, Shinzo; Toh, Uhi; Noguchi, Masanori; Yutani, Shigeru; Yamada, Akira; Shichijo, Shigeki; Yamada, Teppei; Suekane, Shigetaka; Kawano, Kouichiro; Sasada, Tetsuro; Hattori, Noboru; Kohno, Nobuoki; Itoh, Kyogo

Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients

采用丙型肝炎病毒衍生肽和肿瘤相关抗原肽进行个性化肽疫苗治疗丙型肝炎病毒阳性晚期肝细胞癌患者的II期研究

Yutani, Shigeru; Ueshima, Kazuomi; Abe, Kazumichi; Ishiguro, Atsushi; Eguchi, Junichi; Matsueda, Satoko; Komatsu, Nobukazu; Shichijo, Shigeki; Yamada, Akira; Itoh, Kyogo; Sasada, Tetsuro; Kudo, Masatoshi; Noguchi, Masanori